128 related articles for article (PubMed ID: 6265359)
21. Trojan horse lymphocytes: a vesicular stomatitis virus-specific T-cell clone lyses target cells by carrying virus.
Hom RC; Soman G; Finberg R
J Virol; 1989 Oct; 63(10):4157-64. PubMed ID: 2550662
[TBL] [Abstract][Full Text] [Related]
22. Selective and unidirectional membrane redistribution of an H-2 antigen with an antibody-clustered viral antigen: relationship to mechanisms of cytotoxic T-cell interactions.
Geiger B; Rosenthal KL; Klein J; Zinkernagel RM; Singer SJ
Proc Natl Acad Sci U S A; 1979 Sep; 76(9):4603-7. PubMed ID: 228303
[TBL] [Abstract][Full Text] [Related]
23. Minimal molecular and cellular requirements for elicitation of secondary anti-vesicular stomatitis virus cytotoxic T lymphocytes.
Hale AH; Ruebush MJ
J Immunol; 1980 Oct; 125(4):1569-77. PubMed ID: 6251135
[No Abstract] [Full Text] [Related]
24. Antigen-liposome modification of target cells as a method to alter their susceptibility to lysis by cytotoxic T lymphocytes.
Hale AH; Ruebush MJ; Lyles DS; Harris DT
Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6105-8. PubMed ID: 6255476
[TBL] [Abstract][Full Text] [Related]
25. Characterization of dual-reactive H-2Kb-restricted anti-vesicular stomatitus virus and alloreactive cytotoxic T cells.
Sheil JM; Bevan MJ; Lefrancois L
J Immunol; 1987 Jun; 138(11):3654-60. PubMed ID: 3035010
[TBL] [Abstract][Full Text] [Related]
26. Cell membrane antigens recognized by anti-viral and anti-trinitrophenyl cytotoxic T lymphocytes.
Ciavarra R; Forman J
Immunol Rev; 1981; 58():73-94. PubMed ID: 6273294
[No Abstract] [Full Text] [Related]
27. Antibodies against the two serotypes of vesicular stomatitis virus measured by enzyme-linked immunosorbent assay: immunodominance of serotype-specific determinants and induction of asymmetrically cross-reactive antibodies.
Charan S; Hengartner H; Zinkernagel RM
J Virol; 1987 Aug; 61(8):2509-14. PubMed ID: 2439706
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms for generating cell membrane antigens that are recognized by cytotoxic T lymphocytes.
Ciavarra R; Kang CY; Forman J
Fed Proc; 1981 Feb; 40(2):222-7. PubMed ID: 6257559
[TBL] [Abstract][Full Text] [Related]
29. Cytotoxic T lymphocytes reactive with vesicular stomatitis virus: analysis of specificity with monoclonal antibodies directed to the viral glycoprotein.
Lefrancois L; Lyles DS
J Immunol; 1983 Mar; 130(3):1408-12. PubMed ID: 6185583
[TBL] [Abstract][Full Text] [Related]
30. Vesicular stomatitis antigens recognized by cytotoxic cells: analysis with defective interfering particles and reconstituted membrane vesicles.
Ciavarra RP; Kang CY; Forman J
J Immunol; 1980 Jul; 125(1):336-43. PubMed ID: 6247397
[No Abstract] [Full Text] [Related]
31. The glycoprotein isolated from vesicular stomatitis virus is mitogenic for mouse B lymphocytes.
Goodman-Snitkoff G; Mannino RJ; McSharry JJ
J Exp Med; 1981 Jun; 153(6):1489-502. PubMed ID: 6265586
[TBL] [Abstract][Full Text] [Related]
32. An endogenous antigenic peptide bypasses the class I antigen presentation defect in RMA-S.
Hosken NA; Bevan MJ
J Exp Med; 1992 Mar; 175(3):719-29. PubMed ID: 1311017
[TBL] [Abstract][Full Text] [Related]
33. The involvement of Lyt-2 antigens in the lysis of virus-infected target cells by antigen specific anti-vesicular stomatitis virus cytotoxic T-lymphocytes.
Hale AH
Immunol Lett; 1981 Aug; 3(3):179-81. PubMed ID: 6169636
[TBL] [Abstract][Full Text] [Related]
34. Cross-reactive cytotoxic T cells to serologically distinct vesicular stomatitis virus.
Rosenthal KL; Zinkernagel RM
J Immunol; 1980 May; 124(5):2301-8. PubMed ID: 6154097
[No Abstract] [Full Text] [Related]
35. T helper cells in cytotoxic T lymphocyte development: role of L3T4(+)-dependent and -independent T helper cell pathways in virus-specific and alloreactive cytotoxic T lymphocyte responses.
Ciavarra RP
Cell Immunol; 1990 Feb; 125(2):363-79. PubMed ID: 2153464
[TBL] [Abstract][Full Text] [Related]
36. Elicitation of anti-H-2 cytotoxic T lymphocytes with antigen-modified H-2 negative stimulator cells.
Hale AH; Ruebush MJ; Harris DT; McGee MP
J Immunol; 1981 Apr; 126(4):1485-8. PubMed ID: 6970778
[TBL] [Abstract][Full Text] [Related]
37. Antigen processing of vesicular stomatitis virus in situ. Interdigitating dendritic cells present viral antigens independent of marginal dendritic cells but fail to prime CD4(+) and CD8(+) T cells.
Ciavarra RP; Greene AR; Horeth DR; Buhrer K; van Rooijen N; Tedeschi B
Immunology; 2000 Dec; 101(4):512-20. PubMed ID: 11122455
[TBL] [Abstract][Full Text] [Related]
38. In vivo CTL immunity can be elicited by in vitro reconstituted MHC/peptide complex.
Sakita I; Hörig H; Sun R; Wang F; Nathenson SG
J Immunol Methods; 1996 Jun; 192(1-2):105-15. PubMed ID: 8699005
[TBL] [Abstract][Full Text] [Related]
39. Specificity of in vitro cytotoxic T cell clones directed against vesicular stomatitis virus.
Rosenthal KL; Oldstone MB; Hengartner H; Zinkernagel RM
J Immunol; 1983 Jul; 131(1):475-8. PubMed ID: 6190924
[TBL] [Abstract][Full Text] [Related]
40. The soluble viral glycoprotein of vesicular stomatitis virus efficiently sensitizes target cells for lysis by CD4+ T lymphocytes.
Browning M; Reiss CS; Huang AS
J Virol; 1990 Aug; 64(8):3810-6. PubMed ID: 2164598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
